Molecules/INEBILIZUMAB

INEBILIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2020

Mechanism of action: B-lymphocyte antigen CD19 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

INEBILIZUMABINEBILIZUMAB CDONINEBILIZUMAB-CDONMEDI-551MEDI551Uplizna

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to INEBILIZUMAB

Loading drug network...